Modus Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Buy |
11,177
+78
| +0.7% | +$8.65K | 0.37% | 64 |
|
|
2025
Q1 | $1.24M | Buy |
11,099
+125
| +1% | +$14K | 0.41% | 63 |
|
|
2024
Q4 | $1.01M | Buy |
10,974
+487
| +5% | +$45K | 0.32% | 65 |
|
|
2024
Q3 | $879K | Buy |
10,487
+677
| +7% | +$56.8K | 0.29% | 67 |
|
|
2024
Q2 | $673K | Buy |
9,810
+960
| +11% | +$65.9K | 0.24% | 69 |
|
|
2024
Q1 | $648K | Buy |
8,850
+966
| +12% | +$70.8K | 0.24% | 70 |
|
|
2023
Q4 | $639K | Buy |
7,884
+1,650
| +26% | +$134K | 0.26% | 66 |
|
|
2023
Q3 | $467K | Buy |
6,234
+588
| +10% | +$44.1K | 0.2% | 77 |
|
|
2023
Q2 | $435K | Buy |
5,646
+491
| +10% | +$37.8K | 0.19% | 75 |
|
|
2023
Q1 | $428K | Buy |
5,155
+61
| +1% | +$5.06K | 0.2% | 70 |
|
|
2022
Q4 | $437K | Buy |
5,094
+1,058
| +26% | +$90.8K | 0.21% | 69 |
|
|
2022
Q3 | $249K | Buy |
4,036
+28
| +0.7% | +$1.73K | 0.13% | 87 |
|
|
2022
Q2 | $248K | Buy |
4,008
+187
| +5% | +$11.6K | 0.13% | 84 |
|
|
2022
Q1 | $227K | Buy |
3,821
+792
| +26% | +$47.1K | 0.1% | 91 |
|
|
2021
Q4 | $220K | Buy |
+3,029
| New | +$220K | 0.09% | 94 |
|
|
2021
Q3 | – | Sell |
-1,628
| Closed | -$112K | – | 152 |
|
|
2021
Q2 | $112K | Buy |
+1,628
| New | +$112K | 0.05% | 118 |
|
|
2020
Q3 | – | Sell |
-499
| Closed | -$38K | – | 133 |
|
|
2020
Q2 | $38K | Buy |
+499
| New | +$38K | 0.02% | 132 |
|